Jones Financial Companies
CAPR icon

Jones Financial Companies’s Capricor Therapeutics CAPR Stock Holding History

Jones Financial Companies’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.88K Sell
109
-80
-42% -$2.43K ﹤0.01% 4314
2026
Q1 		$5.46K Hold
189
– – ﹤0.01% 3797
2025
Q4 		$5.46K Buy
189
+109
+136% +$1.42K ﹤0.01% 3461
2025
Q3 		$567 Sell
80
-1,916
-96% -$14.1K ﹤0.01% 4020
2025
Q2 		$22.3K Buy
1,996
+1,943
+3,666% +$20.5K ﹤0.01% 2544
2025
Q1 		$610 Buy
+53
New +$736 ﹤0.01% 3489

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jones Financial Companies's CAPR Position: Q2 2026 in Review

Jones Financial Companies reduced its Capricor Therapeutics (CAPR) stake by 42% in Q2 2026, selling an estimated $2.43K and leaving 109 shares worth $2.88K. The position accounts for ﹤0.01% of the portfolio, ranked #4314.

Jones Financial Companies first reported a position in CAPR in Q1 2025 and has held it in 6 quarters since. The position peaked at $22.3K in Q2 2025. 169 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • Jones Financial Companies held 109 shares of Capricor Therapeutics worth $2.88K as of Q2 2026.
  • Jones Financial Companies sold 80 Capricor Therapeutics shares in Q2 2026, an estimated $2.43K.
  • Capricor Therapeutics made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4314 holding.
  • Jones Financial Companies first reported a position in Capricor Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Jones Financial Companies's Capricor Therapeutics position peaked at $22.3K in Q2 2025.
  • 169 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.